A share price of Biodesix Inc [BDSX] is currently trading at $0.49, up 7.96%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The BDSX shares have gain 15.18% over the last week, with a monthly amount glided 9.73%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Biodesix Inc [NASDAQ: BDSX] stock has seen the most recent analyst activity on May 14, 2025, when William Blair downgraded its rating to a Mkt Perform. On July 26, 2024, Craig Hallum initiated with a Buy rating and assigned a price target of $3 on the stock. TD Cowen started tracking the stock assigning a Buy rating and suggested a price target of $2.80 on May 13, 2024. Lake Street initiated its recommendation with a Buy and recommended $3 as its price target on May 03, 2024. Morgan Stanley downgraded its rating to Equal-Weight for this stock on November 17, 2021, and downed its price target to $11. In a note dated November 23, 2020, William Blair initiated an Outperform rating.
Biodesix Inc experienced fluctuations in its stock price throughout the past year between $0.17 and $2.04. Currently, Wall Street analysts expect the stock to reach $3 within the next 12 months. Biodesix Inc [NASDAQ: BDSX] shares were valued at $0.49 at the most recent close of the market. An investor can expect a potential return of 512.24% based on the average BDSX price forecast.
Analyzing the BDSX fundamentals
Trailing Twelve Months sales for Biodesix Inc [NASDAQ:BDSX] were 76.56M which represents 11.68% growth. Gross Profit Margin for this corporation currently stands at 0.79% with Operating Profit Margin at -0.45%, Pretax Profit Margin comes in at -0.54%, and Net Profit Margin reading is -0.54%. To continue investigating profitability, this company’s Return on Assets is posted at -0.47, Equity is -2.7 and Total Capital is -0.47. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of63.39.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.4615 points at the first support level, and at 0.4336 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.5075, and for the 2nd resistance point, it is at 0.5256.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Biodesix Inc [NASDAQ:BDSX] is 2.14. In addition, the Quick Ratio stands at 2.03 and the Cash Ratio stands at 1.37. Considering the valuation of this stock, the price to sales ratio is 0.94, the price to book ratio is 63.08.
Transactions by insiders
Recent insider trading involved Cowie Robin Harper, CFO, Sec’y & Treasurer, that happened on Aug 13 ’25 when 988.0 shares were sold. President & CEO, Hutton Scott completed a deal on Aug 13 ’25 to sell 3772.0 shares. Meanwhile, Chief Commercial Officer O’Kane Kieran sold 476.0 shares on Aug 13 ’25.
